Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The S2 subunit of the SARS-CoV-2 spike glycoprotein mediates fusion between the viral envelope and the host cell membrane, a crucial step for viral entry. It undergoes conformational changes upon proteolytic cleavage, exposing the fusion peptide and driving membrane fusion. It is a target for broadly neutralizing antibodies and next-generation vaccine design.
Inhibition of virus-cell membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SARS-CoV-2 Spike Glycoprotein S2 Subunit (S2).